Sartorius Stedim Biotech S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DIM.PA | STVN | AVTR | RGEN | WST | MMSI | |
|---|---|---|---|---|---|---|
| Market cap | 20.92B | 5.16B | 11.11B | 11.14B | 27.03B | 5.33B |
| P/E (TTM) | 71.4 | 33.2 | — | 240.3 | 49.4 | 36.7 |
| Forward P/E | 35.7 | 22.8 | 18.7 | 65.7 | 38.4 | 19.3 |
| Price/book | 4.9 | 3.0 | 2.0 | 4.7 | 9.0 | 3.2 |
| Dividend yield | 0.31% | 0.33% | — | — | 0.23% | — |
| 1-year change | +3.66% | −26.91% | +8.17% | +13.51% | +41.54% | +7.20% |
| Today | −2.01% | −1.82% | +2.05% | −4.75% | +0.26% | −0.41% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All DIM.PA news ›Sartorius Stedim Biotech (SDMHF) Expected to Announce Earnings on Thursday
Posted by Defense World Staff on Oct 15th, 2026 Sartorius Stedim Biotech (OTCMKTS:SDMHF – Get Free Report) is expected to be announcing its results before the market opens on Thursday, October 22nd. Analysts expect Sartorius Stedim Biotech…
Sartorius Stedim Biotech : Insider Transactions
Follow insider transactions on Sartorius Stedim Biotech in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Sartorius Stedim Biotech Medical Equipment, Supplies &…
Sartorius Stedim Biotech : Barclays remains its Buy rating
Published on 09/08/2026 at 03:06 am EDT Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts European medical equipment makers Sartorius Stedim Biotech: finally,…
Sartorius Stedim Biotech: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Sartorius Stedim Biotech on MarketScreener. Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts…
Sartorius Stedim Biotech : Buy rating from Goldman Sachs
Published on 10/01/2026 at 08:23 am EDT Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts European medical equipment makers Sartorius Stedim Biotech: finally,…
UBS upgrades Sartorius Stedim Biotech to Buy
Sartorius Stedim Biotech is drawing particular attention on the Paris stock market (+4.59%, at 191.30) in a more cautious market that sees the SBF 120 down 0.17%. The stock is being supported by an upgrade from UBS. Published on…
Sartorius Stedim Biotech : JP Morgan reaffirms its Buy rating
Published on 09/28/2026 at 02:21 am EDT Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts European medical equipment makers Sartorius Stedim Biotech: finally,…
Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight
Nav change Change in target price € 253 vs 238 +6.58% The TP increase reflects upgrades to our DCF and NAV . The investment case remains compelling: consumables-led growth, the now-confirmed... Medical Equipment, Supplies & Distribution…
All Transcripts on Sartorius Stedim Biotech (DIM)
Find all the latest transcripts on Sartorius Stedim Biotech Sartorius Stedim Biotech: Recovery and Margin Expansion in Sight October 08, 2026 at 10:14 am EDT Option Care Health deal boosts European medical equipment makers Sartorius Stedim…
Sartorius Stedim Biotech: Relative Strength Chart - Stock Euronext Paris
Compare Sartorius Stedim Biotech with the company of your choice via a Relative Strength chart. Real-time DIM price, Euronext Paris stock exchange Relative Strength Chart Sartorius Stedim Biotech Medical Equipment, Supplies & Distribution…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com16
-
defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.